This invention generally relates the generation of aptamers and to the use
of aptamers as diagnostic and therapeutic agents. More particularly, the
present invention relates to methods using combinatorial chemistry to
prepare aptamers having controlled thiophosphate replacement in the
phosphate backbone for improved binding efficiencies to a target and to
RNA and/or DNA products having novel nucleotide sequences and enhanced
target binding efficacies.
